Получена: 15.01.2024 Принята: 29.01.2024 Опубликована online 29.02.2024
УДК: 614.2
DOI 10.53511/PHARMKAZ.2024.65.85.035

М.С. Шарипова ¹, Ж.В. Романова ¹
¹Казахский Национальный Университет имени Аль-Фараби, Алматы, Казахстан

СТОИМОСТЬ СТАЦИОНАРНОГО ЛЕЧЕНИЯ ВО ВРЕМЯ ПАНДЕМИИ COVID-19,
ОБЗОР ЛИТЕРАТУРЫ

Резюме: Пандемия COVID-19 легла тяжелым бременем на системы здравоохранения по всему миру. Эта ситуация требовала выделения больших ресурсов на систему здравоохранения, особенно
в странах со средним и низким уровнем дохода.
Основной целью данного обзора литературы являлась изучение стоимости стационарного лечения коронавирусной инфекции в мировом здравоохранении путем проведения информационного
поиска литературных данных.
Поиск литературы был проведен в электронных базах Google Scholar, PubMed, открытого доступа, по ключевым словосочетаниям: COVID-19, стационарное лечение, отделение реанимации, стоимость, пандемия. Проведенный литературный обзор по вопросам затрат на стационарное лечение COVID-19 был за период 2020-2023 годы. Критерии включения: статьи, включающие оценку
стоимости лечения у пациентов выше 18 лет. Релевантные с темой работы были включены для
включения в литературный обзор.
Ключевые слова: COVID-19, стационарное лечение, отделение реанимации, стоимость, пандемия

СПИСОК ЛИТЕРАТУРЫ
1 Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.
2 Johns Hopkins University CRCGM. No Title [Internet]. Available from: https://coronavirus.jhu.edu/map.html.
3 Baker S, Bloom N, Davis S, Terry S. COVID-Induced Economic Uncertainty. Natl Bur Econ Res [Internet]. 2020;17. Available from: http://www.nber.org/
papers/w26983
4 Seringa J, Pedreiras S, Freitas MJ, De Matos RV, Rocha J, Millett C, et al. Direct Costs of COVID-19 Inpatient Admissions in a Portuguese Tertiary Care
University Centre. Port J Public Heal. 2022;40(1):26–34.
5 Jin H, Wang H, Li X, Zheng W, Ye S, Zhang S, et al. Economic burden of covid-19, china, january–march, 2020: A cost-of-illness study. Bull World Health
Organ. 2021;99(2):112–24.
6 Здравоохранения В организация. Клиническое ведение тяжелой острой респираторной инфекции при подозрении на коронавирусную инфекцию
COVID-19 [Internet]. Available from: https://www.who.int/ru/emergencies/diseases/novel-coronavirus-2019/technical-guidance
7 Omelyanovsky V V, Avxentyeva M V, Derkach E V, Sveshnikova ND, Expertise E. Анализ стоимости болезни — проблемы и пути решения. 2011;
8 Calderón-Moreno J, Juárez-Vela R, Delgado-Rodríguez MJ, Quintana-Díaz M, Magallón-Botaya R, Olivan-Blázquez B, et al. Approximation to the Consumption
of Healthcare Resources and the Economic Cost of SARS-CoV-2 Patient Management: A Retrospective Study. Front Public Heal. 2022;10(March):1–6.
9 Al Mutair A, Layqah L, Alhassan B, Alkhalifah S, Almossabeh M, AlSaleh T, et al. Estimated cost of treating hospitalized COVID-19 patients in Saudi Arabia.
Sci Rep [Internet]. 2022;12(1):1–7. Available from: https://doi.org/10.1038/s41598-022-26042-z
10 Márquez-González H, Méndez-Galván JF, Reyes-López A, Klünder-Klünder M, Jiménez-Juárez R, Garduño-Espinosa J, et al. Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors. Front Public Heal. 2021;9(July):1–10.
11 Diaz M, HASRA HARTINA, Mayssara A. Abo Hassanin Supervised A, Becerra P, Sanjuan M, Ninla Elmawati Falabiba, et al. No Title No Title No Title.
Cátedra [Internet]. 2018;4(June):105. Available from: http://oa.upm.es/38731/1/TFG_Federico_Gutierrez_Faraoni.pdf%0Ahttp://dspace.redclara.net:8080/
bitstream/10786/1277/1/93 Arquitectura de Software basada en Microservicios para Desarrollo de Aplicaciones Web.pdf%0Ahttp://revistas.unisimon.edu.co/
index.php/i
12 Hesni E, Sayad B, Khosravi Shadmani F, Najafi F, Khodarahmi R, Rahimi Z, et al. Demographics, clinical characteristics, and outcomes of 27,256
hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study. BMC Infect Dis [Internet]. 2022;22(1):1–12. Available
from: https://doi.org/10.1186/s12879-022-07312-7
13 Alwafi H, Naser AY, Qanash S, Brinji AS, Ghazawi MA, Alotaibi B, et al. Predictors of length of hospital stay, mortality, and outcomes among hospitalised
COVID-19 patients in Saudi Arabia: A cross-sectional study. J Multidiscip Healthc. 2021;14:839–52.
14 Torres-Toledano M, Granados-García V, López-Tapia J de J, Miguel-Tiburcio ET, Flores YN, Aracena-Genao B, et al. Costos directos de atención médica
por COVID-19 durante el primer año de pandemia en un hospital reconvertido. Gac Med Mex. 2023;159(3):171–9.
15 Rocha-Filho CR, Martins JWL, Lucchetta RC, Ramalho GS, Trevisani GFM, da Rocha AP, et al. Hospitalization costs of coronaviruses diseases in uppermiddle-income countries: A systematic review. PLoS One. 2022;17(3 March):1–13.
16 Khan AA, Alruthia Y, Balkhi B, Alghadeer SM, Temsah MH, Althunayyan SM, et al. Survival and estimation of direct medical costs of hospitalized covid-19
patients in the kingdom of saudi arabia (Short title: Covid-19 survival and cost in saudi arabia). Int J Environ Res Public Health. 2020;17(20):1–13.
17 Gedik H. The cost analysis of inpatients with COVID-19. Acta Medica Mediterr. 2020;36(6):3289–92.
18 Di Fusco M, Shea KM, Lin J, Nguyen JL, Angulo FJ, Benigno M, et al. Health outcomes and economic burden of hospitalized COVID-19 patients in the
United States. J Med Econ [Internet]. 2021;24(1):308–17. Available from: https://doi.org/10.1080/13696998.2021.1886109
19 Oksuz E, Malhan S, Gonen MS, Kutlubay Z, Keskindemirci Y, Tabak F. COVID-19 healthcare cost and length of hospital stay in Turkey: retrospective analysis
from the first peak of the pandemic. Health Econ Rev. 2021;11(1):1–12.
20 Ohsfeldt RL, Choong CKC, Mc Collam PL, Abedtash H, Kelton KA, Burge R. Inpatient Hospital Costs for COVID-19 Patients in the United States. Adv Ther
[Internet]. 2021;38(11):5557–95. Available from: https://doi.org/10.1007/s12325-021-01887-4
21 Edoka I, Fraser H, Jamieson L, Meyer-Rath G, Mdewa W. Inpatient Care Costs of COVID-19 in South Africa’s Public Healthcare System. Int J Heal Policy
Manag [Internet]. 2022;11(8):1354–61. Available from: https://doi.org/10.34172/ijhpm.2021.24
22 Markey P, Bayliss J, Jones D, Trauer J, Pilcher D, Ademi Z. Estimating Australian Hospitalization Ratios and Costs for Wildtype SARS-CoV-2 in 2020. Curr
Probl Cardiol. 2023;48(11):1–13.
23 Shrestha SS, Kompaniyets L, Grosse SD, Harris AM, Baggs J, Sircar K, et al. Estimation of Coronavirus Disease 2019 Hospitalization Costs From a Large
Electronic Administrative Discharge Database, March 2020-July 2021. Open Forum Infect Dis. 2021;8(12):1–8.
24 Popescu M, Ştefan OM, Ştefan M, Văleanu L, Tomescu D. ICU-Associated Costs during the Fourth Wave of the COVID-19 Pandemic in a Tertiary Hospital
in a Low-Vaccinated Eastern European Country. Int J Environ Res Public Health. 2022;19(3).
25 Abate SM, Ali SA, Mantfardo B, Basu B. Rate of intensive care unit admission and outcomes among patients with coronavirus: A systematic review and
Meta-analysis. PLoS One [Internet]. 2020;15(7 July):1–19. Available from: http://dx.doi.org/10.1371/journal.pone.0235653
26 Ramezani-Doroh V, Tapak L, Hamidi Y, Bashirian S, Soltanian AR, Motaghed M, et al. Which patients bring the most costs for hospital? A study on the cost
determinants among COVID-19 patients in Iran. Cost Eff Resour Alloc [Internet]. 2022;20(1):1–10. Available from: https://doi.org/10.1186/s12962-022-00386-9
27 Dryha NO, Stepanenko A V., Rudenko LA, Zhaldak DO, Piven SM, Plakhtiienko IO. Results of Medical-Social Research on Medical Care Quality for Patients
With Covid-19 of Inpatient Hospital Departments in Sumy Region. Wiad Lek. 2021;74(5):1057–60.
28 Drago G, Pérez-Sádaba FJ, Aceituno S, Gari C, López-Belmonte JL. Healthcare resource use and associated costs in a cohort of hospitalized COVID-19
patients in Spain: A retrospective analysis from the first to the third pandemic wave. EPICOV study. PLoS One. 2023;18(1 January):1–17.
29 Rajabi M, Rezaee M, Omranikhoo H, Khosravi A, Keshmiri S, Ghaedi H, et al. Cost of Illness of COVID-19 and Its Consequences on Health and Economic
System. Inq (United States). 2022;59.
30 Ghaffari Darab M, Keshavarz K, Sadeghi E, Shahmohamadi J, Kavosi Z. The economic burden of coronavirus disease 2019 (COVID-19): evidence from
Iran. BMC Health Serv Res. 2021;21(1):1–7.
31Do Nascimento IJB, de Oliveira ALM, Diniz PHC, Leite M de F, Oliveira GL. Hospitalization, mortality and public healthcare expenditure in Brazil during the
COVID-19 crisis: vulnerabilities in the spotlight. Sao Paulo Med J. 2022;140(2):290–6.
32 Rocha JLL, Riediger I, Gasparetto J, Tuon FF. COVID-19 in real world: Survival and medical costs of hospitalized patients in Brazil´s first wave. Brazilian
J Infect Dis. 2023 Jul 1;27(4):102778.
33 Miethke-Morais A, Cassenote A, Piva H, Tokunaga E, Cobello V, Rodrigues Gonçalves FA, et al. COVID-19-related hospital cost-outcome analysis: The
impact of clinical and demographic factors. Brazilian J Infect Dis. 2021;25(4).
34 Kaso AW, Mohammed E, Agero G, Churiso G, Kaso T, Ewune HA, et al. Assessment of hospitalisation costs and their determinants among Covid-19 patients
in South Central Ethiopia. BMC Health Serv Res. 2023;23(1):1–7.
35 Jeck J, Jakobs F, Kron A, Franz J, Cornely OA, Kron F. A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings
when administering remdesivir during the pandemic “first wave” in a German tertiary care hospital. Infection [Internet]. 2022;50(1):191–201. Available from:
https://doi.org/10.1007/s15010-021-01685-8
36 Yum G, Yue B, Petersburg S. Социально-экономическое и глобальное бремя COVID-19. 2021;24–34.
37 Жидкова ЕА, Шабуров РИ, Черемушкин СВ, Губкин АВ, Рогова ИВ, Попова ИА, et al. Экономические аспекты лечения COVID-19 в условиях
стационара. 2021;41–8.
38 Вечорко В.И., Сычёв Д.А., Кицул И.С. ЧТА. Экономические аспекты лечения вирусной пневмонии, вызванной SARS-CoV-2. ДокторРу. 2022;21/2:46–
50.
39 Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int J Infect
Dis [Internet]. 2022;114:252–60. Available from: https://doi.org/10.1016/j.ijid.2021.11.009
40 Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy,
effectiveness and escape. Nat Rev Immunol [Internet]. 2021;21(10):626–36. Available from: http://dx.doi.org/10.1038/s41577-021-00592-1
41 Thompson MG, Stenehjem E, Grannis S, Ball SW, Naleway AL, Ong TC, et al. Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care
Settings. N Engl J Med. 2021;385(15):1355–71.
42 Somani ST, Firestone RL, Donnelley MA, Sanchez L, Hatfield C, Fine J, et al. Impact of Vaccination on Cost and Course of Hospitalization Associated with
COVID-19 Infection. Antimicrob Steward Healthc Epidemiol. 2023;3(1):1–5.
43 Горошко НВ, Пацала СВ, Емельянова ЕК. Барьеры На Пути Борьбы С Пандемией Covid-19 В Системе Здравоохранения России И Ее Регионов.
Экономика Информатика. 2022;49(2):217–33.

 

количество просмотров / 👁 662